팝업레이어 알림

팝업레이어 알림이 없습니다.

Next-generation macrophage-based immune cell therapy solution

KW-BIO

KW-BIO is leading the innovation in the development of immune cell therapies
that contribute to sustainable health and improved quality of life through continuous research and exploration into the potential of macrophages.

Next-generation macrophage-based immune cell therapy solution

KW-BIO

KW-BIO is leading the innovation in the development of immune cell therapies
that contribute to sustainable health and improved quality of life through continuous research and exploration into the potential of macrophages.

Next-generation macrophage-based immune cell therapy solution

KW-BIO

KW-BIO is leading the innovation in the development of immune cell therapies
that contribute to sustainable health and improved quality of life through continuous research and exploration into the potential of macrophages.

Scroll
KW-BIO

PRODUCT

KW-BIO
Technology & Products

KW-BIO is a leading company developing next-generation
immune cell therapies by integrating induced pluripotent
stem cell technology, gene editing technology, AI-based
technology, and material delivery technology with
macrophages, an innate immune cell.

ABOUT US

CUSTOMER

NOTICE

  • There are no posts.

DATA

Share KW-BIO's technical
data and other useful resources.

View More
DATA 이미지
  • Head office. 302, 32 Sicheong-gil, Chuncheon-si, Gangwon-do (Joyang-dong)
  • Gyeonggi Office. 718, Ace Smart Wing Yeongtong Knowledge Industry Center, 253 Samseong-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do
  • Corporate Research Institute. 730, Ace Smart Wing Yeongtong Knowledge Industry Center, 253 Samseong-ro, Yeongtong-gu, Suwon-si, Gyeonggi-do
  • CEO. Jang Hee-soon
  • E-mail. kwbio@kwbio.co.kr
Privacy Policy
TOP TOP
Copyright (C) 2024 KW-BIO. All Rights Reserved.

Privacy Policy